The "Elevate" by MAPS Podcast

The role of real-world evidence (RWE) in Medical Affairs has greatly evolved in the last few years. The clinical evidence regarding the potential benefits or risks of a therapy generated from data relating to patient health or the delivery of health care can add value at every stage of a product’s lifecycle. RWE can not only help support a product’s safe and appropriate use in a post-approval sett...

Conference prep requires more than placing publications, securing booth space and scheduling as many KOL meetings as possible. Here we speak with Chris Medieros, Director of Strategic Insights, H1, about how to maximize your organization's presence and impact at congresses, including how to plan strategically across the workflow of KOL interactions.

In today's episode of the MAPS "Elevate" podcast, we'll be looking at considerations for Medical Affairs in Rare Disease and Gene Therapy and reviewing the following questions: How do you the see the role of Medical Affairs evolving in the era of advance therapeutics like gene therapy, often investigated for rare disorders? Are there specialized skillsets MA professionals need...

This series of the Elevate Podcast illuminates the path scientific communication takes from teaching to diagnosis to treating all the way to changing, prolonging, and saving patient lives. External Education of a growing variety of stakeholders in healthcare by the Medical Affairs Division of Pharma and Medical Device industry reflects the critical role Education in Medicine plays in our Age of In...

In this episode of the Elevate podcast series, MAPS speaks with experts from Altmetric about tackling the challenges of an expanding world and understanding who is communicating research by measuring Share of Voice.  This episode is sponsored by Altmetric. 

How and why medical publishing is changing and where is it going in the future. The benefits of digital-first development of manuscripts. How enhanced content can improve publication access and resonance.

MAPS speaks with Tim Mikelhashvili and winners of his Medical Affairs Innovation Olympics about applications that can match patients with clinical trials and provide real-time input to provide context for clinical decisions.

When we think about Medical Insights, the first function that comes to mind is Field Medical and capturing/analyzing MSL/HCP interactions in ways that lead to strategic actions. But there are other sources of insights, including the Medical Information function. Many organizations are already capturing and quantifying MedInfo requests to learn more about the types of questions HCPs are asking. Now...

On today's episode, we're Speaking with Tim Mikhelashvili, CEO and Co-Founder of Amedea Pharma, and the winners of his Medical Affairs Olympics Competition who dared to come together to share ideas across MA functions. This podcast is sponsored by Amedea Pharma.

This series of the Elevate Podcast illuminates the path scientific communication takes from teaching to diagnosis to treating all the way to changing, prolonging, and saving patient lives. External Education of a growing variety of stakeholders in healthcare by the Medical Affairs Division of Pharma and Medical Device industry reflects the critical role Education in Medicine plays in our Age of In...

How do you deliver impactful medical education? Hear from industry experts how to design medical education programs successfully for today’s healthcare professionals, in our latest podcast episode, sponsored by Wiley.

In today's episode, we're talking with Joseph Zabinski, PhD, Senior Director, AI & Personalized Medicine at OM1 about Artificial Intelligence — specifically about how AI can accelerate diagnosis and treatment. This episode is sponsored by OM1.

Today we're talking about publications impact with Mike Taylor, Head of Data Insights and GRONYA Farrell, Manager Corporate Life Science, Central Europe, both at Digital Science. We'll discuss the questions: Where are we now? Are we looking beyond impact factor?  And how to do we make sense of the data and translate "numbers" into "actionable insights".  This episode...

Post-approval safety studies have traditionally been cumbersome and expensive, and safety study sites are likely to mirror those used in clinical trials, leading organizations to potentially miss safety signals in populations beyond those that typically participate at trial sites. Here we speak with Stefan C. Weiss, MD, Managing Director, Dermatology at OM1 about a transformation in the way we con...

As technology changes the ways we engage with external stakeholders, the skills we need to manage these interactions are changing, as well. Here we speak with Jen Millard, Vice President of Field Medical at IQVIA, about emerging competencies for external engagement. This episode is sponsored by IQVIA. 

Patient communities continue to mobilize and play an increasingly important role by influencing many elements of the drug development journey and subsequent patient access and support activities. This input ranges from natural history studies, recruitment in clinical trials, understanding burden, contributing to Health Technology Assessments and co-creating educational resources that enable shared...

This podcast series focuses on how digital is transforming scientific communications.   In this, our second episode this season, we'll be discussing open access in medical publishing from the biopharma perspective.

In this Opening Doors episode of the Medical Affairs Professional Society podcast series, Elevate, we speak with Áine Prendergast, Medical Science Liaison in Oncology with Ipsen. Hear about Áine's path into the profession and learn important advice that can help you find a first MSL position.

In this second podcast in this series, we will discuss delivering constructive feedback.

On today's episode of the MAPS "Elevate" podcast, we're discussing the use of Real-World Evidence to understand and possibly intercede in treatment-resistant depression and why is it especially difficult to develop treatments against resistant depression using the traditional structure of R&D-led clinical trials.

This podcast series focuses on how digital is transforming scientific communications.  Season 2 Episode 1 will focus on the struggles and successes of compliance in Medical Communications.  Season 2 Episode 2 will focus on the journal publishing industry, discussing how medical journal publishing is transforming and what changes we might see in the future.  Season 2 Episodes 3 and 4 will focus on...

Opening Doors episodes of the MAPS Elevate Podcast Series give Medical Affairs professionals the opportunity to tell the story of how they found their way into the profession and to offer advice to others seeking Medical Affairs positions. Here MAPS co-founder, Kirk Shepard, speaks with Niha Yerneni, Medical Scientific Affairs Manager at Ironwood Pharmaceuticals about joining Medical Affairs and,...

With the evolving role of Medical Communications in Medical Affairs, greater partnership and integration in Medical Strategy Planning is key to improve overall Medical Affairs outcomes. Enhanced collaboration between these groups drives strong MedComms execution, leading to increased awareness in the HCP, payer, and regulatory communities. During these podcasts, experienced Medical Strategy and Co...

The pharmaceutical and MedTech industries, and specifically Medical Affairs knows how far we are behind big tech in our ability to mine data for meaning. Here MAPS speaks with Mark Michalski, former radiologist and currently Worldwide Head, Healthcare & Life Sciences, Artificial Intelligence and Machine Learning, Amazon Web Services about how we can catch up — from predictive analytics in the...

With the evolving role of Medical Communications in Medical Affairs, greater partnership and integration in Medical Strategy Planning is key to improve overall Medical Affairs outcomes. Enhanced collaboration between these groups drives strong MedComms execution, leading to increased awareness in the HCP, payer, and regulatory communities. During these podcasts, experienced Medical Strategy and Co...